Clinical Epidemiology in Contemporary Patients With Myelofibrosis (ERNEST-3): A European LeukemiaNet (ELN) Observational Study
Status: Recruiting
Location: See all (36) locations...
Study Type: Observational
SUMMARY
Multicenter retrospective and prospective European observational study. At each site, all consecutive patients with a 2016- or 2022 World Health Organization (WHO) confirmed diagnosis of myelofibrosis (MF) established from 01/01/2018 to 31/12/2027 will be enrolled into the study. Yearly follow-up updates will be scheduled until the end of data collection on 31/12/2028 or until the last available patient visit, whichever comes first. At least 1 year of follow-up will be ensured from the last patient enrolled.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 100
Healthy Volunteers: f
View:
• Diagnosis of primary myelofibrosis (PMF) or secondary (i.e., post-ET/PV MF) myelofibrosis according to 2016- or 2022-WHO criteria ascertained between 01/01/2018 and 31/12/2027
• Age ≥ 18 years
• Signed informed consent where applicable, in line with current European General Data Protection Regulation (GDPR) directives
Locations
Other Locations
Armenia
Hematology Center after Prof.R.H. Yeolyan
RECRUITING
Yerevan
Denmark
University of Copenhagen's Roskilde Hospital
NOT_YET_RECRUITING
Copenhagen
France
Clinical Investigation Center of the Saint Louis Hospital
NOT_YET_RECRUITING
Paris
Germany
Internal Medicine C, Hematology, Oncology, Stem Cell Transplantation and Palliative Care, University Medicine Greifswald
NOT_YET_RECRUITING
Greifswald
University Hospital Halle Department of Hematology/Oncology
NOT_YET_RECRUITING
Halle
University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care Johannes Wesling Medical Center Minden UKRUB, University of Bochum
NOT_YET_RECRUITING
Minden
Israel
Division of Haematology, Sasson University Hospital Assuta Ashdod, Ashdod, Ben-Gurion University of Negev
NOT_YET_RECRUITING
Ashdod
Italy
A.S.O. SS. Antonio e Biagio e C.Arrigo, SC Ematologia
RECRUITING
Alessandria
ASST Papa Giovanni XXIII, SC Ematologia
RECRUITING
Bergamo
Policlinico S. Orsola - Malpighi, Unità di Ematologia
RECRUITING
Bologna
Azienda Ospedaliero - Universitaria Policlinico Vittorio Emanuele - PO Gaspare Rodolico, Dipartimento di ematologia con Trapianto di midollo Osseo
NOT_YET_RECRUITING
Catania
AOU Careggi di Firenze, Divisione di Ematologia
RECRUITING
Florence
ASST Grande Ospedale Metropolitano Niguarda, Divisione di Ematologia
NOT_YET_RECRUITING
Milan
Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Ematologia
RECRUITING
Milan
Ospedale San Raffaele, Unità Operativa di Ematologia e Trapianto Midollo Osseo
RECRUITING
Milan
Fondazione IRCCS San Gerardo dei Tintori
RECRUITING
Monza
Azienda Ospedaliera Universitaria Federico II, Divisione di Ematologia
RECRUITING
Naples
Azienda Ospedaliero Universitaria Maggiore della Carità, SCDU Ematologia
RECRUITING
Novara
Azienda Ospedale-Università di Padova, Dipartimento di Medicina
NOT_YET_RECRUITING
Padova
Università degli Studi di Padova - Policlinico Universitario, Clinica Medica 1
NOT_YET_RECRUITING
Padova
Fondazione IRCCS Policlinico San Matteo, Divisione di Ematologia
RECRUITING
Pavia
Fondazione Policlinico Universitario A. Gemelli - Università Cattolica del Sacro Cuore, UCSC Ematologia
NOT_YET_RECRUITING
Roma
Policlinico Umberto I, Dipartimento Ematologia, Oncologia e Dermatologia
RECRUITING
Roma
A.O.U. Città della Salute e della Scienza di Torino - Ospedale Molinette- S.C. Ematologia U
NOT_YET_RECRUITING
Torino
ASST dei Sette Laghi (Ospedale di Circolo e F. Macchi), Divisione U.O. Ematologia
NOT_YET_RECRUITING
Varese
Azienda Ospedaliera Universitaria Integrata - Ospedale Borgo Roma, Unità di Ematologia
RECRUITING
Verona
Azienda ULSS 8 Berica - Ospedale San Bortolo, Divisione di Ematologia
NOT_YET_RECRUITING
Vicenza
Poland
Department of Hematology, University Hospital, Jagiellonian University Medical College
RECRUITING
Krakow
Department and Clinic of Haematology, Blood Neoplasms, and Bone Marrow Transplantation, Wroclaw Medical University
RECRUITING
Wroclaw
Republic of Moldova
Institute of Oncology, State University of Medicine and Pharmacy - Department of Oncology, Hematology and Radiotherapy
NOT_YET_RECRUITING
Chisinau
Romania
Department of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute
RECRUITING
Bucharest
Spain
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) - Hospital Clinic
RECRUITING
Barcelona
Hematology and Hemotherapy Department, 12 de Octubre University Hospital
RECRUITING
Madrid
Servicio de Hematología - Hospital Clínico Universitario de Valencia
NOT_YET_RECRUITING
Valencia
United Kingdom
School of Medicine, Dentistry and Biomedical Sciences Queen's University Belfast
NOT_YET_RECRUITING
Belfast
Guy's and St. Thomas' NHS Foundation Trust.
NOT_YET_RECRUITING
London
Contact Information
Primary
TIZIANO BARBUI, MD
tbarbui@fondazionefrom.it
0352675134
Backup
FENILI
sperimentazioni@fondazionefrom.it
Time Frame
Start Date: 2024-10-14
Estimated Completion Date: 2028-12-31
Participants
Target number of participants: 617
Related Therapeutic Areas
Sponsors
Leads: FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Collaborators: GlaxoSmithKline